Chronic cconstipation
Conditions
Interventions
unapproved medical device
Sponsors
Kamiya Takeshi
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients with chronic constipation who are aware of constipation and are taking laxatives internally 2. Male or female patients, between 20 and 85 years of age at the time of consent 3. Patients whose written consent has been obtained prior to yje initiation of any procedure related to this study
Exclusion criteria
Exclusion criteria: 1. Patients with suspected obstruction or stenosis of gastrointestinal tract 2. Patients with a history of abdominal or pelvic surgery 3. Patients with malignant diseases of the abdomen or pelvic area 4. Patients with a history of allergic reaction or hypersensitivity to Barium 5. Patients with dysphagia 6. Patients with infllamatory bowel disease 7. Patients who are pregnant, lactating or may be pregnant 8. Other patients who are juged by the principal investigator or sub-investigator to be inappropriate as research subjects
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence and severity of adverse events after the intake of radio-paque markers | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Visibillty of radio-peque markers 2. Distribution of radio-paque markers in the colon after 5 dyas of intake 3. Confirmation of excretion of all markwes after 4-8 weeks of intake | — |
Contacts
Public ContactTakeshi Kamiya
Nagoya City University Hospital
Outcome results
None listed